Larvol Delta - Imara-Receives-Orphan-Drug-Designation-from-the-European-Commission-for-IMR687-for-the-Treatment-of-Sickle-Cell-Disease

IMR-687 - Imara, Inc

https://www.globenewswire.com/news-release/2020/08/25/2083108/0/en/Imara-Receives-Orphan-Drug-Designation-from-the-European-Commission-for-IMR-687-for-the-Treatment-of-Sickle-Cell-Disease.html

Aug 25, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next